ISMPP Highlights
Author Selection Practices Recommended by ISMPP Authorship Task Force – Now Published in CMRO
Author selection based on ICMJE criterion 1 can be challenging, particularly for multicenter trials with a large number of investigators and contributors. The ISMPP Authorship Task Force was formally launched in 2019 to define author selection best practices for industry-sponsored medical publications. The recommendations were published in CMRO on April 19, 2022…
“In The Know” – Key Updates in Medical Communications
“In The Know” highlights various updates in medical publications and communications: New CHEERS 2022 Guidance, Preprints in ICMJE Recommendations, Carbon Costs of In-Person vs Virtual Medical Conferences, Readability and Format of PLS, AI-Assisted Tools in Scholarly Communications, Peer Review Congress in September 2022…
GPP4 – The Latest Update as Interest Grows
Excitement is building as the fourth iteration of the Good Publication Practice (also known as GPP4) guidance nears completion. At the 2022 European Meeting of ISMPP in late January, Dan Bridges (CEO, Nucleus Global) of the GPP4 Steering Committee presented information on the team’s progress. Watch the video to view this GPP4 update…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Getting Started: Social Media and Scientific Communications
Healthcare professionals are increasingly using social media to find relevant information that informs their practice. Alongside researchers and publishers, the pharmaceutical and biotechnology industries have a responsibility to provide healthcare professionals with trustworthy, timely and accurate scientific data about the products they research and develop, and the diseases they treat…
The Role of Preprint Servers and Publishers in Limiting Misinformation: An Interview
The opportunities for preprint servers and traditional publishers to limit misinformation for their users is an area of broad interest in the wake of the COVID-19 pandemic in 2020 and 2021, with its impact continuing into 2022 and beyond. This insightful interview was conducted with Jan Seal-Roberts and Caroline Halford of Adis, Springer Healthcare, and Richard Sever of Cold Spring Harbor Laboratory Press, bioRxiv, and medRxiv…
THE FUTURE OF ADVISORY BOARDS – Is This the End of the In-Person Format?
When writing The MAP article, “Advisory Boards: Words of Advice and a 10-point Checklist”, released in March 2020, we could not have predicted the era of unprecedented change that was to come. Many pharmaceutical companies had already been reaping the benefits of fully virtual advisory boards pre-COVID-19, but the necessity to move all meetings to a fully online format required a significant shift in strategy and mindset…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Adverse Event Inclusion Just Before Abstract Submission
A medical writer worked with authors to develop a congress abstract for a Phase 2 clinical study. Two days before submission, the lead author requests an additional ‘medical narrative’ statement to be added detailing the management steps and time to resolution of an adverse event seen in one patient. What would you do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals